AcelRx Pharmaceuticals

375 articles with AcelRx Pharmaceuticals

• AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results

  8/10/2012

• AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference

  8/8/2012

• AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012

  8/8/2012

• AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms

  8/1/2012

• AcelRx Pharmaceuticals Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

  7/23/2012

• AcelRx Pharmaceuticals to Webcast, Live, at RetailInvestorConferences.com on July 12th

  7/11/2012

• AcelRx Pharmaceuticals to Present at the JMP Securities Healthcare Conference 2012

  6/29/2012

• AcelRx Pharmaceuticals Receives First U.S. Patent for Small-Volume Oral Transmucosal Dosage Forms

  6/20/2012

• AcelRx Pharmaceuticals to Present at the Jefferies and Co. 2012 Global Healthcare Conference

  6/4/2012

• AcelRx Pharmaceuticals Completes Private Placement of $10.0 Million

  6/4/2012

• AcelRx Pharmaceuticals Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing

  5/30/2012

• AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results

  5/8/2012

• AcelRx Pharmaceuticals Announces Hiring of Kim Gaumer as Vice President, Regulatory Affairs and Quality Assurance

  4/17/2012

• AcelRx Pharmaceuticals Announces Initiation of Second Phase 3 Clinical Trial for ARX-01, the Sufentanil NanoTab® PCA System, for the Treatment of Acute Post-Operative Pain

  4/12/2012

• AcelRx Pharmaceuticals Receives Two Notices of Allowance for Small-Volume Oral Transmucosal Dosage Forms

  4/11/2012

• AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results

  3/20/2012

• AcelRx Pharmaceuticals Announces Initiation of Phase 3 Clinical Program for ARX-01, the Sufentanil NanoTab(R) PCA System for the Treatment of Post-Operative Pain

  3/7/2012

• AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences

  2/21/2012

• AcelRx Pharmaceuticals Announces its ARX-01 Phase 3 Program Expected to Start Late Q1 or Early Q2 2012

  1/31/2012

• AcelRx Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference

  11/23/2011